JS

Jann Skinner

Telix Pharmaceuticals Limited | Non-Executive Director
Ms Skinner has financial acumen, accounting and auditing expertise, with an understanding of risk management compliance frameworks and control oversight. Her listed company experience and expertise in capital management and corporate development enable her to challenge management constructively. Ms Skinner has experience in auditing, accounting and in the insurance industry. She was a partner of PricewaterhouseCoopers for 17 years before retiring in 2004. She has served as an independent Non-Executive Director of QBE Insurance Group Limited (since October 2014) and a Director of Create Foundation Limited (since June 2004). She also served as a Director of HSBC Bank Australia Limited (from April 2017 to April 2023). SHe is member of People, Culture Committee and Disclosure Committee and chair of Risk Committee.

Companies and Roles

Company
Title
Tenure
Since
TLX
Telix Pharmaceuticals Limited
  • Non-Executive Director
5yrs, 10mthJun 2018
QBE
QBE Insurance Group Limited
  • Non-Executive Director
9yrs, 6mthOct 2014

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TLX
Telix Pharmaceuticals Limited
22/02/24N/A595,000N/AN/A
QBE
QBE Insurance Group Limited
30/12/23N/A70,000N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TLX
Telix Pharmaceuticals Limited
09/11/22
Issued
495,000$1.090$539,550Exercise of options
TLX
Telix Pharmaceuticals Limited
09/11/22
Exercise
495,000$1.090$539,550Exercise of options
QBE
QBE Insurance Group Limited
08/03/21
Buy
6,005$9.500$57,047On-market trade
QBE
QBE Insurance Group Limited
20/05/20
Issued
3,995$7.510$30,002Participation in share purchase plan
QBE
QBE Insurance Group Limited
11/03/20
Buy
10,000$11.100$111,000On-market trade